Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [619]
News [1052]
Articles [54]
Editorials [2]
Conferences [97]
elearning [5]
The AZURE translational study
Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK
The AZURE translational study ( Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK )
14 Dec 2012
Prognostic signatures in colon cancer
Dr Ramon Salazar – Catalan Institut of Oncology, Barcelona, Spain
Prognostic signatures in colon cancer ( Dr Ramon Salazar – Catalan Institut of Oncology, Barcelona, Spain )
7 Dec 2012
HDAC inhibitors sensitise triple-negative breast cancer cells to PARP...
Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA
HDAC inhibitors sensitise triple-negative breast cancer cells to PARP inhibition and cisplatin treatment ( Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA )
6 Dec 2012
Gestational trophoblastic disease tumours in high risk patients
Dr Michael Seckl – Charing Cross Hospital, Imperial College London, UK
Gestational trophoblastic disease tumours in high risk patients ( Dr Michael Seckl – Charing Cross Hospital, Imperial College London, UK )
30 Oct 2012
State of PARP inhibitors and anti-angiogenics
Prof Stan Kaye – Royal Marsden Hospital, London, UK
State of PARP inhibitors and anti-angiogenics ( Prof Stan Kaye – Royal Marsden Hospital, London, UK )
29 Oct 2012
Defining and advancing individualised medicine
Prof Anil Sood – MD Anderson Cancer Centre, Houston, USA
Defining and advancing individualised medicine ( Prof Anil Sood – MD Anderson Cancer Centre, Houston, USA )
29 Oct 2012
Analysing the efficacy of treatment through Response Evaluation Criteria in...
Dr Yves Menu – Saint Antoine Hospital, Paris, France
Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST) ( Dr Yves Menu – Saint Antoine Hospital, Paris, France )
9 Oct 2012
Standard of care for neo-adjuvant therapy in HER 2 and triple negative subtype
Dr Fatima Cardoso – Champalimaud Cancer Center, Lisbon, Portugal
Standard of care for neo-adjuvant therapy in HER 2 and triple negative subtype ( Dr Fatima Cardoso – Champalimaud Cancer Center, Lisbon, Portugal )
9 Oct 2012
Advances in advanced prostate cancer from ESMO 2012; focus on abiraterone...
Dr Chris Parker , Dr Charles Ryan, Prof Karim Fizazi
Advances in advanced prostate cancer from ESMO 2012; focus on abiraterone acetate ( Dr Chris Parker , Dr Charles Ryan, Prof Karim Fizazi )
9 Oct 2012
Putting the theory of personalised medicine into practice
Prof Fabrice Andre, Dr Ramesh Ramanathan, Prof Peter Harper and Prof Robert...
Putting the theory of personalised medicine into practice ( Prof Fabrice Andre, Dr Ramesh Ramanathan, Prof Peter Harper and Prof Robert Leonard )
8 Oct 2012
Personalised cancer medicine and research: Today’s best practice
Prof José Baselga - Massachusetts General Hospital, Boston, USA
Personalised cancer medicine and research: Today’s best practice ( Prof José Baselga - Massachusetts General Hospital, Boston, USA )
5 Oct 2012
Too few women being offered breast-conserving treatment?
Dr Carmen Criscitiello - European Institute of Oncology in Milan, Italy
Too few women being offered breast-conserving treatment? ( Dr Carmen Criscitiello - European Institute of Oncology in Milan, Italy )
30 Sep 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation